About Contact Us Careers

Multiple System Atrophy Market Trends

Request Free Sample Copy

Report ID: 3440
Published Date: Aug 27, 2024
Report Format: PDF, PPT

Buy Now

Multiple System Atrophy Market Trends

Growth Drivers

Growing Occurrence of Multiple System Atrophy Across the World
Increasing Research and Development Activities to Develop Effective Treatment for Systemic Atrophies

Challenges

Lack of Awareness about the Disease in Lower Economic Regions

Multiple System Atrophy (MSA) Market: Key Insights

Base Year	2023
Forecast Year	2024-2036
CAGR	4.5%
Base Year Market Size (2023)	USD 139.4 million
Forecast Year Market Size (2036)	USD 247.04 million
Regional Scope	North America (U.S., and Canada) Asia Pacific (Japan, China, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia Pacific) Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Latin America (Mexico, Argentina, Brazil, Rest of Latin America) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

Multiple System Atrophy (MSA) Market Size & Share, Growth Forecasts 2036

Author Credits: Radhika Pawar

Report ID: 3440
Published Date: Aug 27, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of multiple system atrophy is assessed at USD 144.42 million.

Multiple System Atrophy (MSA) Market size was over USD 139.4 million in 2023 and is anticipated to reach USD 247.04 million by 2036, growing at around 4.5% CAGR during the forecast period i.e., between 2024-2036. The market growth is impelled by growing occurrence of multiple system atrophy across the world and increasing research and development activities to develop effective treatment for systemic atrophies.

Asia Pacific is set to account for largest revenue share by 2036, on the back of increasing number of cases of multiple system atrophy, especially in Japan, high patient pool and growing government initiatives to improve the infrastructure of healthcare in the region.

The major players in the market are Chelsea Therapeutics International, Ltd., Biohaven Pharmaceuticals, Inc., Sumitomo Dainippon Pharma Co., Ltd., AstraZeneca plc, and others.

Inquiry Before Buying Request Free Sample